ARTIFICIAL INTELLIGENCE, THE NEW ALLY IN HEALTH

ARTICLE BY FÁTIMA MARINA (ATREVIA) / The fact that Artificial Intelligence (AI) is a hot topic is nothing new. That is why FundéuRAE chose, in 2022, this term as word of the year, and in 2023, so did Collins Dictionary. Its evolution has been rapid and it has been gaining relevance in many sectors, but if there is one in which it has burst onto the scene with force, it is in the field of healthcare. 

By Fátima Marina, Health Director ATREVIA Barcelona 

At the clinical level, AI has become a powerful ally in the detection and prevention of certain chronic diseases and in the fight against aging, which are major challenges for Spanish healthcare. 

Technology has shown that it can help healthcare professionals in diagnostic decision making by offering personalized recommendations to the patient. But for this to happen, it is essential to empower patients and make them aware of their responsibility in their healthcare in order to achieve adherence to treatment. And it is here where communication campaigns aimed at patients become very important to generate awareness as we are promoting in ATREVIA.

Another key role for AI is in primary care. A recent study indicated that its use in diagnosis can reduce medical errors by up to 30%, underscoring its potential to improve clinical accuracy and reduce the burden on healthcare professionals. AI is not going to solve the problems of primary care, but it can support the professionals who work there. There are routines that technology can help to solve with more quality, more precision, leaving the doctor and other healthcare professionals with what is really important: having more time to attend to patients. 

Its role in the pharmaceutical industry is also key. AI has been shown to help in drug manufacturing processes, anticipate problems in production equipment and improve drug quality control. 

Public administration is also benefiting from its implementation. Public health systems can use the technology to analyze epidemiological data and detect disease outbreaks, facilitating rapid and effective responses. COVID19 was an example of this. Its use also allows for greater operational efficiency in the management of health resources, optimizing the allocation of personnel, equipment and medical supplies. In this sense, it ensures that they are used effectively while reducing waste. 

Despite its advantages, AI has also raised fears. Privacy and security of patient data is a primary concern, as AI systems handle large volumes of sensitive information. So is equity in access to AI technologies and transparency in the use of their algorithms. Added to this is the need to reinforce citizen confidence at a time marked by the dissemination of false and misleading information that can have serious health consequences. 

To address this and encourage the development of secure AI, the EU has recently approved the new Artificial Intelligence Act (AI Act), which establishes a pioneering regulatory framework. Organizations will have to ensure transparency and traceability of data and commit to its ethical use. 

There is still a long way to go. Although the speed of its evolution is dizzying, the key is undoubtedly to see AI as an ally and not as an enemy. 

Click here to access the original content published in TOP Comunicación 

Serendipia Newsletter

Keep abreast of all the news ATREVIA and trends in the world of communication
Subscribe

Where are we

Spain Portugal Brussels Argentina Bolivia Brazil Chile Colombia Ecuador Dominican republic Mexico Miami Panama Paraguay Peru

Madrid

C/ Arturo Soria, 99

28043 - Madrid

Tel. (+34) 91 564 07 25

madrid@atrevia.com

Tell us

Barcelona

Trav. de les Corts, 55

08028 - Barcelona

Tel. (+34) 93 419 06 30

barcelona@atrevia.com

Tell us

Valencia

C/Cirilo Amorós, 68

46004 - Valencia

Tel. (+34) 96 394 33 14

valencia@atrevia.com

Tell us

A Coruña

Avenida de Buenos Aires, 5-6

15004 - A Coruña

Tel. (+34) 881 255 363

galicia@atrevia.com

Tell us

Lisbon

Avda. da Liberdade, 157

1250-141 - Lisbon

Tel. (+351) 213 240 227

lisboa@atrevia.com

Tell us

Porto

Rua de Costa Cabral, 777 A

4200-212 - Porto

Tel. (+351) 933 461 279 / (+351) 92 672 82 92

porto@atrevia.com

Tell us

Brussels

Rue de Trèves 49-51 à 1040

Etterbeek - Brussels

Tel. (+32) 2511 6527

bruselas@atrevia.com

Tell us

Buenos Aires

Moreno 502

Ciudad Autónoma de Buenos Aires - CAPITAL FEDERAL

argentina@atrevia.com

Tell us

Santa Cruz

Santa Cruz - Bolivia

Tel. (+591) 67155444

bolivia@atrevia.com

Tell us

Sao Paulo

Av. Ibirapuera, 2120, Cjto. 134

Sao Paulo – Brasil

Tel. (+55) 11 000718080

brasil@atrevia.com

Tell us

Santiago

Alcantara 200 304

Las Condes Santiago - Chile

Tel. Las Condes Santiago - Chile

chile@atrevia.com

Tell us

Bogota

Cra 15 # 88-21. Torre Unika Virrey. Oficina 602

Bogota - Colombia

Tel. (+57) 3506614527

bolivia@atrevia.com

Tell us

Quito

Avda. Amazonas 3123 y Azuay. Edificio Copladi. Piso 8

Quito - Ecuador

Tel. (+593) 987164389

ecuador@atrevia.com

Tell us

Guayaquil

Edificio Sky Building. Oficina 423

Ciudadela Bahía Norte Mz 57 - Guayaquil

Tel. (+593) 987164389

ecuador@atrevia.com

Tell us

Santo Domingo

Regus Santo Domingo. Roble Corporate Center. Planta 7

Rafael Auusto Sánchez 86, Piantini – Santo Domingo

rd@atrevia.com

Tell us

Mexico City

Enrique Wallon 414. Piso 2. Col. Polanco V sección, Alc. Miguel Hidalgo

11580 - Mexico City

Tel. (+52) 55 5922 4262

mexico@atrevia.com

Tell us

Miami

Brickell Key Drive 602

FL 33131 - Miami

usa@atrevia.com

Tell us

Panama

Banistmo Tower. Planta 10. Aquilinio de la Guardia St.

Marbella - Panama

panama@atrevia.com

Tell us

Asunción

Capitán Solano Escobar 294

Asunción - Paraguay

paraguay@atrevia.com

Tell us

Lima

Av. Camino Real Nº456 Oficina 1003-1004

Torre Real, San Isidro - Lima

Tel. (+51) 652-2422

peru@atrevia.com

Tell us